UBS Group’s Churchill Capital Corp VII Units CVIIU Stock Holding History

UBS Group’s Portfolio CVIIU Stock Details CVIIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43	Closed	-$464	–	10309
2024 Q1	$464	Sell	43 -1,457	-97%	-$15.2K	﹤0.01%	8542
2023 Q4	$15.8K	Buy	+1,500	New	+$15.8K	﹤0.01%	7241
2023 Q2	–	Sell	-1,100	Closed	-$11.2K	–	9930
2023 Q1	$11.2K	Sell	1,100 -1,288	-54%	-$13K	﹤0.01%	7527
2022 Q4	$23.8K	Buy	2,388 +52	+2%	+$517	﹤0.01%	7471
2022 Q3	$23K	Sell	2,336 -705	-23%	-$6.93K	﹤0.01%	7225
2022 Q2	$30K	Buy	3,041 +806	+36%	+$7.94K	﹤0.01%	6404
2022 Q1	$22K	Sell	2,235 -1,210	-35%	-$11.9K	﹤0.01%	7363
2021 Q4	$35K	Sell	3,445 -26,721	-89%	-$267K	﹤0.01%	7237
2021 Q3	$298K	Buy	30,166 +2,987	+11%	+$29.7K	﹤0.01%	5050
2021 Q2	$272K	Buy	27,179 +1,704	+7%	+$17.1K	﹤0.01%	5142
2021 Q1	$254K	Buy	+25,475	New	+$263K	﹤0.01%	5317

Other funds holding CVIIU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group's CVIIU Position: Q2 2024 in Review

UBS Group sold out of Churchill Capital Corp VII Units (CVIIU) in Q2 2024, closing a stake of 43 shares — an estimated $464 sold.

UBS Group first reported a position in CVIIU in Q1 2021 and held it in 11 quarters. The position peaked at $298K in Q3 2021. 2 funds tracked by Wall St. Rank hold CVIIU as of Q2 2024.

UBS Group reported no remaining Churchill Capital Corp VII Units position as of Q2 2024 after selling out during the quarter.
UBS Group sold 43 Churchill Capital Corp VII Units shares in Q2 2024, an estimated $464.
UBS Group first reported a position in Churchill Capital Corp VII Units in Q1 2021 and held it in 11 quarters.
UBS Group's Churchill Capital Corp VII Units position peaked at $298K in Q3 2021.
2 funds tracked by Wall St. Rank held Churchill Capital Corp VII Units as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.